ロード中...
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
Gastric cancer (GC) is frequently diagnosed and treated in advanced tumour stages with poor prognosis. Recent studies have identified isoform 2 of the tight junction protein claudin-18 (CLDN18.2) as a promising target in GC therapy. In this study, we aimed to outline the expression of CLDN18.2 and i...
保存先:
| 出版年: | Virchows Arch |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6861347/ https://ncbi.nlm.nih.gov/pubmed/31332522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00428-019-02624-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|